{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:52:18Z","timestamp":1792086738573,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:00:00Z","timestamp":1626480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","award":["RG-1435-80"],"award-info":[{"award-number":["RG-1435-80"]}],"id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jsps.2021.07.019","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T21:49:04Z","timestamp":1626904144000},"page":"963-975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Preparation, characterization, dissolution, and permeation of flibanserin \u2212 2-HP-\u03b2-cyclodextrin inclusion complexes"],"prefix":"10.1007","volume":"29","author":[{"given":"Adel F.","family":"Alghaith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6285-9863","authenticated-orcid":false,"given":"Gamal M.","family":"Mahrous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diaa Eldin","family":"Zidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil A.","family":"Alhakamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmohsin J.","family":"Alamoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awwad A.","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2021.07.019_b0005","doi-asserted-by":"crossref","first-page":"117491","DOI":"10.1016\/j.saa.2019.117491","article-title":"Determination of flibanserin in the presence of confirmed degradation products by a third derivative emission spectrofluorometric method: Application to pharmaceutical formulation","volume":"225","author":"Ahmed","year":"2020","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"issue":"5","key":"10.1016\/j.jsps.2021.07.019_b0010","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1111\/j.1743-6109.2010.01763.x","article-title":"Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: a microdialysis study","volume":"7","author":"Allers","year":"2010","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.jsps.2021.07.019_b0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.molliq.2017.12.006","article-title":"Effect of beta-cyclodextrin and different surfactants on solubility, stability, and permeability of hydrochlorothiazide","volume":"250","author":"Altamimi","year":"2018","journal-title":"J. Mol. Liq."},{"issue":"2","key":"10.1016\/j.jsps.2021.07.019_b0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2007.07.018","article-title":"The utility of cyclodextrins for enhancing oral bioavailability","volume":"123","author":"Carrier","year":"2007","journal-title":"J. Control. Release."},{"issue":"4","key":"10.1016\/j.jsps.2021.07.019_b0025","first-page":"1442","article-title":"Factorial study on the effects of beta-cyclodextrin and sodium lauryl sulphate on the solubility and dissolution rate of celecoxib tablets","volume":"23","author":"Chowdary","year":"2011","journal-title":"Asian J. Chem."},{"issue":"4","key":"10.1016\/j.jsps.2021.07.019_b0030","first-page":"228","article-title":"A factorial study on the effects of HP\u03b2-cyclodextrin, PVP K30 and SLS on the solubility and dissolution rate of Efavirenz","volume":"2","author":"Chowdary","year":"2011","journal-title":"Int. J. Appl. Biol. Pharm. Technol."},{"key":"10.1016\/j.jsps.2021.07.019_b0035","doi-asserted-by":"crossref","first-page":"631","DOI":"10.4103\/0250-474X.29632","article-title":"Effect of polyvinylpyrrolidone on complexation and dissolution rate of \u03b2- cyclodextrin and hydroxypropyl \u03b2- cyclodextrin complexes of celecoxib","volume":"68","author":"Chowdary","year":"2006","journal-title":"Indian J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.jsps.2021.07.019_b0040","first-page":"237","article-title":"Flibanserin (Addyi): The first FDA-approved treatment for female sexual interest\/arousal disorder in premenopausal women","volume":"42","author":"English","year":"2017","journal-title":"P T"},{"key":"10.1016\/j.jsps.2021.07.019_b0045","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.2147\/IJN.S258791","article-title":"Optimized nanostructured lipid carriers integrated into in situ nasal gel for enhancing brain delivery of flibanserin","volume":"15","author":"Fahmy","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"45","key":"10.1016\/j.jsps.2021.07.019_b0050","doi-asserted-by":"crossref","first-page":"26109","DOI":"10.1039\/C9RA04448E","article-title":"Preparation and characterization of cyanazine-hydroxypropyl-beta-cyclodextrin inclusion complex","volume":"9","author":"Gao","year":"2019","journal-title":"RSC Adv."},{"issue":"4","key":"10.1016\/j.jsps.2021.07.019_b0055","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4103\/0975-1483.104365","article-title":"Studies on the preparation, characterization, and solubility of 2-HP-beta-cyclodextrin-meclizine HCl inclusion complexes","volume":"4","author":"George","year":"2012","journal-title":"J. Young. Pharm."},{"issue":"3","key":"10.1016\/j.jsps.2021.07.019_b0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/0975-1483.83759","article-title":"Preparation and Evaluation of Silymarin beta-cyclodextrin molecular inclusion complexes","volume":"3","author":"Ghosh","year":"2011","journal-title":"J. Young. Pharm."},{"issue":"2","key":"10.1016\/j.jsps.2021.07.019_b0065","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.tca.2006.03.003","article-title":"The use of DSC curves to determine the acetylation degree of chitin\/chitosan samples","volume":"444","author":"Guinesi","year":"2006","journal-title":"Thermochimica Acta."},{"key":"10.1016\/j.jsps.2021.07.019_b0070","first-page":"117","article-title":"Phase-solubility techniques","volume":"4","author":"Higuchi","year":"1965","journal-title":"Adv. Anal. Chem. Instrument."},{"issue":"7","key":"10.1016\/j.jsps.2021.07.019_b0075","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.bjp.0705341","article-title":"Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors","volume":"139","author":"Invernizzi","year":"2003","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.jsps.2021.07.019_b0080","doi-asserted-by":"crossref","DOI":"10.1208\/pt050345","article-title":"Effect of pH-sodium lauryl sulfate combination on solubilization of PG-300995 (an anti-HIV agent): a technical note","volume":"5","author":"Jain","year":"2004","journal-title":"Aaps. Pharmscitech."},{"issue":"7","key":"10.1016\/j.jsps.2021.07.019_b0085","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/jsm.12189","article-title":"Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial","volume":"10","author":"Katz","year":"2013","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.jsps.2021.07.019_b0090","first-page":"77","article-title":"Macromolecular and modeling aspects of swelling-controlled systems","author":"Korsmeyer","year":"1983","journal-title":"Controlled Release Delivery Syst."},{"issue":"3\u20134","key":"10.1016\/j.jsps.2021.07.019_b0095","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10847-016-0598-z","article-title":"Inclusion complexes of fluconazole with beta-cyclodextrin and 2-hydroxypropyl-beta-cyclodextrin in aqueous solution: preparation, characterization and a structural insight","volume":"84","author":"Li","year":"2016","journal-title":"J. Inclusion Phenomena Macrocyclic Chem."},{"issue":"9","key":"10.1016\/j.jsps.2021.07.019_b0100","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1002\/jps.23077","article-title":"Cyclodextrins as functional excipients: Methods to enhance complexation efficiency","volume":"101","author":"Loftsson","year":"2012","journal-title":"J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.jsps.2021.07.019_b0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpharm.2005.05.042","article-title":"Evaluation of cyclodextrin solubilization of drugs","volume":"302","author":"Loftsson","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.jsps.2021.07.019_b0110","first-page":"237","article-title":"Methods to enhance the complexation efficiency of cyclodextrins","volume":"9","author":"Loftsson","year":"1999","journal-title":"STP Pharma. Sci."},{"issue":"4","key":"10.1016\/j.jsps.2021.07.019_b0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-4362.1998.00369.x","article-title":"Cyclodextrins: new drug delivery systems in dermatology","volume":"37","author":"Loftsson","year":"1998","journal-title":"Int. J. Dermatol."},{"issue":"1","key":"10.1016\/j.jsps.2021.07.019_b0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0169-409X(98)00055-6","article-title":"Cyclodextrins in ophthalmic drug delivery","volume":"36","author":"Loftssona","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3\u20134","key":"10.1016\/j.jsps.2021.07.019_b0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10847-007-9321-4","article-title":"Enhancement of cyclosporine aqueous solubility using alpha- and hydroxypropyl beta-cyclodextrin mixtures","volume":"59","author":"Malaekeh-Nikouei","year":"2007","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"issue":"1","key":"10.1016\/j.jsps.2021.07.019_b0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(98)00056-8","article-title":"Cyclodextrins in transdermal and rectal delivery","volume":"36","author":"Matsuda","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jsps.2021.07.019_b0135","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.foodhyd.2017.10.029","article-title":"Factors affecting the entrapment efficiency of beta-cyclodextrins and their effects on the formation of inclusion complexes containing essential oils","volume":"77","author":"Neto","year":"2018","journal-title":"Food Hydrocolloids"},{"issue":"2","key":"10.1016\/j.jsps.2021.07.019_b0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0928-0987(99)00002-0","article-title":"Determination of stability constant of beta-cyclodextrin complexes using the membrane permeation technique and the permeation behavior of drug-competing agent-beta-cyclodextrin ternary systems","volume":"8","author":"Ono","year":"1999","journal-title":"Eur. J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.jsps.2021.07.019_b0145","first-page":"1651","article-title":"Physicochemical characterization and dissolution properties of binary systems of pyrimethamine and 2-hydroxypropyl-beta-cyclodextrin","volume":"8","author":"Onyeji","year":"2009","journal-title":"Afr. J. Biotechnol."},{"issue":"12","key":"10.1016\/j.jsps.2021.07.019_b0150","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3109\/03639045.2010.488647","article-title":"Evaluation of the impact of sodium lauryl sulfate source variability on solid oral dosage form development","volume":"36","author":"Qiang","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"2","key":"10.1016\/j.jsps.2021.07.019_b0155","first-page":"84","article-title":"Formulation and Evaluation of Cyclodextrin Inclusion Complex Tablets of Carvedilol","volume":"10","author":"Raj","year":"2016","journal-title":"Asian J. Pharma."},{"issue":"5","key":"10.1016\/j.jsps.2021.07.019_b0160","first-page":"583","article-title":"Poorly water-soluble drugs for oral delivery - A challenge for pharmaceutical development - Part III: drug delivery systems containing the drug molecularly dispersed - Aspects on in vitro and in vivo characterization","volume":"67","author":"Rasenack","year":"2005","journal-title":"Pharm. Ind."},{"issue":"2","key":"10.1016\/j.jsps.2021.07.019_b0165","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.3390\/ijms14023671","article-title":"Synthesis and Characterization of the Inclusion Complex of beta-cyclodextrin and Azomethine","volume":"14","author":"Sambasevam","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.jsps.2021.07.019_b0170","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.2042-7158.1995.tb03267.x","article-title":"Effect of 2-hydroxypropyl-beta-cyclodextrin on percutaneous absorption of methyl paraben","volume":"47","author":"Tanaka","year":"1995","journal-title":"J. Pharm. Pharmacol."},{"issue":"5","key":"10.1016\/j.jsps.2021.07.019_b0175","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1021\/cr970025p","article-title":"Cyclodextrin drug carrier systems","volume":"98","author":"Uekama","year":"1998","journal-title":"Chem. Rev."},{"issue":"2","key":"10.1016\/j.jsps.2021.07.019_b0180","first-page":"S394","article-title":"Cyclodextrin complexes: an approach to improve the physicochemical properties of drugs and applications of cyclodextrin complexes","volume":"12","author":"Vikas","year":"2018","journal-title":"Asian J. Pharma."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016421001468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016421001468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:26:27Z","timestamp":1736184387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016421001468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1319016421001468"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2021.07.019","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation, characterization, dissolution, and permeation of flibanserin \u2212 2-HP-\u03b2-cyclodextrin inclusion complexes","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2021.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}